4-[(13bR)-5b,8,8,11a-tetramethyl-3a-[2-(1-oxo-1,4-thiazinan-4-yl)ethylamino]-2,3,4,5,5a,6,7,7a,11,11b,12,13,13a,13b-tetradecahydro-1H-cyclopenta[a]chrysen-9-yl]benzoic acid

C38H56N2O3S — CID 144681927

IUPAC4-[(13bR)-5b,8,8,11a-tetramethyl-3a-[2-(1-oxo-1,4-thiazinan-4-yl)ethylamino]-2,3,4,5,5a,6,7,7a,11,11b,12,13,13a,13b-tetradecahydro-1H-cyclopenta[a]chrysen-9-yl]benzoic acid
SMILESCC1(C)C(c2ccc(C(=O)O)cc2)=CCC2(C)C1CCC1(C)C3CCC4(NCCN5CCS(=O)CC5)CCC[C@@H]4C3CCC12
InChIInChI=1S/C38H56N2O3S/c1-35(2)29(26-7-9-27(10-8-26)34(41)42)13-17-37(4)32(35)15-18-36(3)30-14-19-38(39-20-21-40-22-24-44(43)25-23-40)16-5-6-31(38)28(30)11-12-33(36)37/h7-10,13,28,30-33,39H,5-6,11-12,14-25H2,1-4H3,(H,41,42)/t28?,30?,31-,32?,33?,36?,37?,38?/m1/s1
InChIKeyMYZLWYGYYGZYJF-ASXUKEKLSA-N
MW620.94 g/mol
LogP7.25
Rot. Bonds6

About 4-[(13bR)-5b,8,8,11a-tetramethyl-3a-[2-(1-oxo-1,4-thiazinan-4-yl)ethylamino]-2,3,4,5,5a,6,7,7a,11,11b,12,13,13a,13b-tetradecahydro-1H-cyclopenta[a]chrysen-9-yl]benzoic acid

4-[(13bR)-5b,8,8,11a-tetramethyl-3a-[2-(1-oxo-1,4-thiazinan-4-yl)ethylamino]-2,3,4,5,5a,6,7,7a,11,11b,12,13,13a,13b-tetradecahydro-1H-cyclopenta[a]chrysen-9-yl]benzoic acid (PubChem CID 144681927) has the molecular formula C38H56N2O3S and a molecular weight of 620.94 g/mol. Its IUPAC name is 4-[(13bR)-5b,8,8,11a-tetramethyl-3a-[2-(1-oxo-1,4-thiazinan-4-yl)ethylamino]-2,3,4,5,5a,6,7,7a,11,11b,12,13,13a,13b-tetradecahydro-1H-cyclopenta[a]chrysen-9-yl]benzoic acid.

Molecular Properties

Compound Name4-[(13bR)-5b,8,8,11a-tetramethyl-3a-[2-(1-oxo-1,4-thiazinan-4-yl)ethylamino]-2,3,4,5,5a,6,7,7a,11,11b,12,13,13a,13b-tetradecahydro-1H-cyclopenta[a]chrysen-9-yl]benzoic acid
PubChem CID144681927
Molecular FormulaC38H56N2O3S
Molecular Weight620.94 g/mol
Exact Mass620.40
IUPAC Name4-[(13bR)-5b,8,8,11a-tetramethyl-3a-[2-(1-oxo-1,4-thiazinan-4-yl)ethylamino]-2,3,4,5,5a,6,7,7a,11,11b,12,13,13a,13b-tetradecahydro-1H-cyclopenta[a]chrysen-9-yl]benzoic acid
SMILESCC1(C)C(c2ccc(C(=O)O)cc2)=CCC2(C)C1CCC1(C)C3CCC4(NCCN5CCS(=O)CC5)CCC[C@@H]4C3CCC12
InChIInChI=1S/C38H56N2O3S/c1-35(2)29(26-7-9-27(10-8-26)34(41)42)13-17-37(4)32(35)15-18-36(3)30-14-19-38(39-20-21-40-22-24-44(43)25-23-40)16-5-6-31(38)28(30)11-12-33(36)37/h7-10,13,28,30-33,39H,5-6,11-12,14-25H2,1-4H3,(H,41,42)/t28?,30?,31-,32?,33?,36?,37?,38?/m1/s1
InChIKeyMYZLWYGYYGZYJF-ASXUKEKLSA-N
XLogP7.25
TPSA69.64 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds6
Heavy Atoms44
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500620.94
LogP ≤ 57.25
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Analyze 4-[(13bR)-5b,8,8,11a-tetramethyl-3a-[2-(1-oxo-1,4-thiazinan-4-yl)ethylamino]-2,3,4,5,5a,6,7,7a,11,11b,12,13,13a,13b-tetradecahydro-1H-cyclopenta[a]chrysen-9-yl]benzoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[(13bR)-5b,8,8,11a-tetramethyl-3a-[2-(1-oxo-1,4-thiazinan-4-yl)ethylamino]-2,3,4,5,5a,6,7,7a,11,11b,12,13,13a,13b-tetradecahydro-1H-cyclopenta[a]chrysen-9-yl]benzoic acid?
The IUPAC name of 4-[(13bR)-5b,8,8,11a-tetramethyl-3a-[2-(1-oxo-1,4-thiazinan-4-yl)ethylamino]-2,3,4,5,5a,6,7,7a,11,11b,12,13,13a,13b-tetradecahydro-1H-cyclopenta[a]chrysen-9-yl]benzoic acid (CID 144681927) is 4-[(13bR)-5b,8,8,11a-tetramethyl-3a-[2-(1-oxo-1,4-thiazinan-4-yl)ethylamino]-2,3,4,5,5a,6,7,7a,11,11b,12,13,13a,13b-tetradecahydro-1H-cyclopenta[a]chrysen-9-yl]benzoic acid.
What is the SMILES notation for 4-[(13bR)-5b,8,8,11a-tetramethyl-3a-[2-(1-oxo-1,4-thiazinan-4-yl)ethylamino]-2,3,4,5,5a,6,7,7a,11,11b,12,13,13a,13b-tetradecahydro-1H-cyclopenta[a]chrysen-9-yl]benzoic acid?
The canonical SMILES for 4-[(13bR)-5b,8,8,11a-tetramethyl-3a-[2-(1-oxo-1,4-thiazinan-4-yl)ethylamino]-2,3,4,5,5a,6,7,7a,11,11b,12,13,13a,13b-tetradecahydro-1H-cyclopenta[a]chrysen-9-yl]benzoic acid is CC1(C)C(c2ccc(C(=O)O)cc2)=CCC2(C)C1CCC1(C)C3CCC4(NCCN5CCS(=O)CC5)CCC[C@@H]4C3CCC12.
What is the InChIKey of 4-[(13bR)-5b,8,8,11a-tetramethyl-3a-[2-(1-oxo-1,4-thiazinan-4-yl)ethylamino]-2,3,4,5,5a,6,7,7a,11,11b,12,13,13a,13b-tetradecahydro-1H-cyclopenta[a]chrysen-9-yl]benzoic acid?
The InChIKey is MYZLWYGYYGZYJF-ASXUKEKLSA-N. The full InChI is InChI=1S/C38H56N2O3S/c1-35(2)29(26-7-9-27(10-8-26)34(41)42)13-17-37(4)32(35)15-18-36(3)30-14-19-38(39-20-21-40-22-24-44(43)25-23-40)16-5-6-31(38)28(30)11-12-33(36)37/h7-10,13,28,30-33,39H,5-6,11-12,14-25H2,1-4H3,(H,41,42)/t28?,30?,31-,32?,33?,36?,37?,38?/m1/s1.
What are the key properties of 4-[(13bR)-5b,8,8,11a-tetramethyl-3a-[2-(1-oxo-1,4-thiazinan-4-yl)ethylamino]-2,3,4,5,5a,6,7,7a,11,11b,12,13,13a,13b-tetradecahydro-1H-cyclopenta[a]chrysen-9-yl]benzoic acid?
4-[(13bR)-5b,8,8,11a-tetramethyl-3a-[2-(1-oxo-1,4-thiazinan-4-yl)ethylamino]-2,3,4,5,5a,6,7,7a,11,11b,12,13,13a,13b-tetradecahydro-1H-cyclopenta[a]chrysen-9-yl]benzoic acid has a molecular weight of 620.94 g/mol, XLogP of 7.25, 6 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[(13bR)-5b,8,8,11a-tetramethyl-3a-[2-(1-oxo-1,4-thiazinan-4-yl)ethylamino]-2,3,4,5,5a,6,7,7a,11,11b,12,13,13a,13b-tetradecahydro-1H-cyclopenta[a]chrysen-9-yl]benzoic acid is sourced from PubChem (CID 144681927), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).